Cancer Screening and Preventive Services Panel’s Uncertain Future

A federal task force responsible for shaping guidelines on cancer screenings, heart disease prevention, and other health services hasn’t met in nearly a year, raising questions about when—or if—it will convene again.

The U.S. Preventive Services Task Force, established in 1984, comprises volunteer doctors, nurses, and public health experts who assess recent scientific studies to determine which preventive care options should be provided at no cost to patients.

According to the Affordable Care Act, most private insurers are mandated to cover services that earn an A or B grade from this task force. This affects over 150 million individuals with private insurance, including about 37 million children, as highlighted in a 2022 report from the Department of Health and Human Services. Additionally, roughly 20 million adults enrolled in Medicaid and 61 million on Medicare also benefit from this provision.

The task force generally meets three times annually—in March, July, and November. Its last gathering was in March 2025, while a July session was canceled, and plans for a November meeting were halted due to the government shutdown. So far, there are no announcements for a March meeting either.

The task force is currently operating with a reduced number of members, as five terms expired last year and have yet to be filled, leaving only 11 members instead of the usual 16.

Dr. Alex Krist, who chaired the task force from 2020 to 2021, noted that several draft recommendations are still awaiting finalization. These include updates on cervical cancer screening and screening for perinatal depression.

While the panel meets virtually most weeks, Krist—who is no longer involved—mentioned that official votes on recommendations occur only during scheduled meetings. Typically, they produce around 20 to 25 recommendations each year, yet only about five were published last year.

“These recommendations can save lives,” Krist explained. “For clinicians, the task force serves as our guiding principle for preventive care.”

The Agency for Healthcare Research and Quality, under the Department of Health and Human Services, oversees the task force’s activities. However, uncertainty looms as Health Secretary Robert F. Kennedy Jr. has made changes to other federal advisory panels.

Last June, Kennedy replaced all members of the Advisory Committee on Immunization Practices (ACIP), which provides vaccine guidance to the CDC. A similar decrease in public meetings has also been observed in the FDA’s Advisory Committee on Vaccines.

Kennedy possesses the authority to appoint and dismiss members of the Preventive Services Task Force as well. Reports suggest he has criticized the panel for being too “woke.” Some insiders indicated he was contemplating a complete overhaul of its members. In a letter dated July 27, the American Medical Association urged Kennedy to keep the current panel intact.

A spokesperson for HHS did not respond to inquiries regarding potential changes or whether the task force would meet in March.

Dorit Reiss, a law professor at the University of California College of the Law, San Francisco, underscored that the task force’s mission should remain free from political influences.

“Like ACIP, the USPSTF is designed to provide unbiased, science-based advice on health issues,” Reiss stated. “If it’s politicized, that undermines its purpose and makes doctors less likely to follow the guidance.”

The panel faced political scrutiny in the past when conservative groups challenged the Department of Health and Human Services over its endorsement of the HIV prevention drug PrEP. Although the case posed a threat to the ACA’s preventive care mandate, the Supreme Court ultimately upheld the requirement that insurers cover panel-recommended services.

To date, the task force has 54 recommendations mandated for insurance coverage. These include biennial mammograms starting at age 40, anxiety screenings for children from age 8, and statin prescriptions for certain patients aged 40 to 75 with at least one heart disease risk factor.

Dr. Robert Lawrence, the first chair of the task force, expressed concerns that the nuances of health risks across diverse populations, such as LGBTQ individuals and Black women facing higher maternal mortality rates, might be dismissed by Kennedy as being overly “woke.”

“Given RFK Jr.’s anti-science stance on vaccines and other HHS issues, I fear the same fate may befall the task force,” Lawrence commented. He co-authored an opinion piece recently stating that dismantling the task force would be detrimental to clinical practice.

Typically, task force recommendations are reviewed every five years as new research comes to light. Lawrence worries that without regular meetings, necessary updates may be delayed.

The reduced size of the panel might also hinder its capability to evaluate evidence and issue new guidelines.

“I can’t help but worry we might revert to a time before evidence-based medicine,” he said.